mots c vs retatrutide My & MOTS-c Stack Is Running Out… End of the Cycle Before Summer?! #Retatrutide #Reta Mots C vs Retatrutide |
Description
Overall, diabetes management was doing fine Until incretin-based therapy entered the scene and shook things up
Large multicenter trials (including ERICCA and RIPHeart) showed no reduction in major adverse cardiac events with RPc 60
Statistical adjustment for antiparkinson medication use did not change the findings
The key differentiator mechanistically is GCGR activation: tirzepatide has no glucagon component
Those who transitioned from high dose Zepbound to Foundayo regained about 5 kg (11 lbs) on average over the same period
